Pentair slides as Q1 revenue misses despite EPS beat and raised 2026 outlook

PNRPNR

Pentair shares are down about 3% after reporting Q1 2026 results that beat on adjusted EPS but came in slightly light on revenue. The stock is reacting to the top-line miss and a cautious near-term setup even as the company lifted its full-year 2026 EPS outlook.

1. What’s moving the stock today

Pentair (PNR) is trading lower today after releasing first-quarter 2026 results that exceeded profit expectations but fell short on revenue, prompting investors to focus on demand and volume trends rather than margin execution. The selling pressure appears tied to the revenue miss and “good-but-not-great” read-through for near-term growth, even though management updated (raised) the full-year earnings outlook.

2. The key numbers investors are reacting to

In its Q1 2026 update, Pentair reported net sales of about $1.04 billion and adjusted diluted EPS of $1.22, alongside GAAP diluted EPS of $0.98. The company also provided an updated outlook, including a Q2 adjusted EPS range of roughly $1.47 to $1.50 and a higher full-year 2026 EPS view—signals that profitability is holding up, but the market is still discounting the modest top-line performance.

3. Why the market can still sell a beat

For multi-industrials tied to discretionary and replacement cycles, revenue trajectory often matters more than an EPS beat driven by mix and cost controls. A revenue miss can raise questions about end-market momentum (notably heading into peak pool season) and whether future growth will require heavier promotions or investment, limiting the upside investors were positioned for after the prior run-up.

4. What to watch next

Traders will focus on commentary around segment demand, order patterns, and pricing versus volume, plus any details on how the company expects sales to track through the rest of 2026. The next catalysts are the conference call Q&A tone, confirmation of second-quarter assumptions, and whether Pentair can convert margin strength into re-accelerating organic growth.